| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| enGene Holdings Inc. | Director | Stock Option (Right to Buy) | 22,500 | 16 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ENGN | enGene Holdings Inc. | 16 Jun 2025 | 1 | $0 | 4 | Director | 16 Jun 2025, 18:37 |
| ENGN | enGene Holdings Inc. | 15 Jun 2024 | 1 | $0 | 4 | Director | 18 Jun 2024, 16:04 |
| ENGN | enGene Holdings Inc. | 20 Feb 2024 | 2 | +$8,000,000 | 4 | Director, 10%+ Owner | 21 Feb 2024, 16:20 |
| ENGN | enGene Holdings Inc. | 31 Oct 2023 | 12 | $0 | 4 | Director, 10%+ Owner | 02 Nov 2023, 16:07 |
| ENGN | enGene Holdings Inc. | 31 Oct 2023 | 0 | $0 | 3 | Director | 31 Oct 2023, 18:00 |
| LVAC | LAVA Medtech Acquisition Corp. | 26 Oct 2021 | 0 | $0 | 3 | President, Director | 26 Oct 2021, 17:50 |